Financials INSPECS Group plc

Equities

Delayed London S.E. Other stock markets 10:04:16 2024-06-10 am EDT			5-day change	1st Jan Change
55.32 ^GBX	-2.95%		-27.21%	-34.14%

Jun. 06	Inspecs falls as interim revenue expected to fall annually	AN
Jun. 06	TRAFIGURA PUBLISHES 2024 HALF YEAR RESULTS…	RE

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	457.1	507	52.88	108.7	73.73	-	-
Enterprise Value (EV) ¹	504.3	562.1	110.5	150.8	121.4	116	109.5
P/E ratio	-	-	-6.5 x	-87.7 x	-189 x	142 x	51.7 x
Yield	-	0.25%	-	-	-	-	-
Capitalization / Revenue	9.64 x	2.06 x	0.21 x	0.43 x	0.28 x	0.26 x	0.25 x
EV / Revenue	10.6 x	2.28 x	0.44 x	0.6 x	0.45 x	0.41 x	0.37 x
EV / EBITDA	86.9 x	26.2 x	5.75 x	6.72 x	4.87 x	4.43 x	3.99 x
EV / FCF	-150 x	-	131 x	21.8 x	17.6 x	10.8 x	9.12 x
FCF Yield	-0.67%	-	0.76%	4.59%	5.68%	9.25%	11%
Price to Book	-	-	-	-	-	-	-
Nbr of stocks (in thousands)	101,291	101,291	101,672	101,672	101,672	-	-
Reference price ²	4.512	5.006	0.5201	1.069	0.7252	0.7252	0.7252
Announcement Date	6/18/21	6/29/22	4/27/23	4/17/24	-	-	-

¹USD in Million²USD

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	-	47.42	246.5	248.6	252.8	268.1	280.6	292
EBITDA ¹	-	5.8	21.48	19.2	22.43	24.9	26.17	27.45
EBIT ¹	-	3.501	-	10.86	14.81	16.73	17.62	18.64
Operating Margin	-	7.38%	-	4.37%	5.86%	6.24%	6.28%	6.38%
Earnings before Tax (EBT) ¹	-	-11.16	-	-9.481	0.2674	2.937	4.213	5.618
Net income ¹	6.44	-	-	-	-1.24	-0.383	0.511	1.532
Net margin	-	-	-	-	-0.49%	-0.14%	0.18%	0.52%
EPS ²	-	-	-	-0.0800	-0.0122	-0.003830	0.005110	0.0140
Free Cash Flow ¹	-	-3.367	-	0.842	6.915	6.895	10.72	12
FCF margin	-	-7.1%	-	0.34%	2.74%	2.57%	3.82%	4.11%
FCF Conversion (EBITDA)	-	-	-	4.38%	30.83%	27.69%	40.98%	43.72%
FCF Conversion (Net income)	-	-	-	-	-	-	2,098.83%	783.42%
Dividend per Share	-	-	0.0125	-	-	-	-	-
Announcement Date	5/12/20	6/18/21	6/29/22	4/27/23	4/17/24	-	-	-

¹USD in Million²USD

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	47.2	55.1	57.6	42.1	47.6	42.3	35.7
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	8.136 x	2.566 x	3 x	1.877 x	1.913 x	1.615 x	1.302 x
Free Cash Flow ¹	-	-3.37	-	0.84	6.92	6.9	10.7	12
ROE (net income / shareholders' equity)	-	-	-	-	-	-	-	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share	-	-	-	-	-	-	-	-
Cash Flow per Share ²	-	-0.0100	0.1900	0.0500	0.1200	0.1100	0.1300	0.1400
Capex ¹	-	2.62	-	4.24	5.75	5.11	2.55	2.55
Capex / Sales	-	5.52%	-	1.7%	2.27%	1.9%	0.91%	0.87%
Announcement Date	5/12/20	6/18/21	6/29/22	4/27/23	4/17/24	-	-	-

¹USD in Million²USD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

C-

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.7252 USD

Average target price

1.277 USD

Spread / Average Target

+76.05%

	1st Jan change	Capi.
INSPECS GROUP PLC	-34.14%	73.73M
ALCON INC.	+24.19%	45.32B
THE COOPER COMPANIES, INC.	-0.72%	18.79B
AUTEK CHINA INC.	-22.28%	2.17B
WARBY PARKER INC.	+16.95%	1.98B
PEGAVISION CORPORATION	+20.05%	1.14B
MINGYUE OPTICAL LENS CO.,LTD.	-41.45%	679M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-7.76%	667M
MENICON CO., LTD.	-45.13%	628M
SHANGHAI CONANT OPTICAL CO., LTD.	+56.94%	605M